Genetic deficiency of NOD2 confers resistance to invasive aspergillosis
Mark S. Gresnigt(Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI)), Frank L. van de Veerdonk(Radboud University Nijmegen), Anne Ammerdorffer(Radboud University Nijmegen), Rosalie Lubbers(Charles River Laboratories (Netherlands)), Orhan Raşid(Institutul Cantacuzino), Marije Oosting(Radboud University Nijmegen), João F. Lacerda(University of Lisbon), Oumaïma Ibrahim-Granet(Institut Pasteur), António Campos(Instituto Português de Oncologia Francisco Gentil), Cristina Cunha(Ipca Laboratories (India)), R. K. Subbarao Malireddi(St. Jude Children's Research Hospital), Catherine Fitting(Institut Pasteur), Thirumala‐Devi Kanneganti(St. Jude Children's Research Hospital), Grégory Jouvion(Institut Pasteur), Katrien Lagrou(KU Leuven), Dirk J. de Jong(Radboud University Nijmegen), Agostinho Carvalho(University of Perugia), Johan Maertens(Unknown), Willem J. G. Melchers(Radboud University Nijmegen), Martin Jaeger(Radboud University Nijmegen), Samuel M. Gonçalves(University of Minho)
Cited by 57
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
|Clinical Infectious Diseases|2002|2.3k
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
|New England Journal of Medicine|2007|1.8k